Af-001

· Alpha Fusion Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Af-001, covering 2025-12-31 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer [Phase 1]